Satellite Symposia

Satellite symposia are organised by industrial companies and take place at lunchtime as well as in the evening in order to avoid time conflicts with the main scientific programme. During these sessions cutting-edge information on interventional equipment and techniques is provided.



Wednesday, April 25

	11:45-12:30
SY 301	Delcath Systems, Inc.	Main Auditorium
	Chemosaturation therapy: initial European experiences
	Moderator: R. Lencioni (Pisa/IT)
301.1       301.2     301.3	First European centre experience with chemosaturation: an IR's perspective on the procedure F. Orsi (Milan/IT) Chemosaturation therapy as part of patient management: an oncologist's view P.F. Ferrucci (Milan/IT) Chemosaturation therapy: an IR's perspective on where it fits now and in the future T.J. Vogl (Frankfurt/DE)
	12:30-13:15
SY 302	Covidien	Main Auditorium
	Tumour ablation: extending the boundaries
	Moderator: F. Orsi (Milan/IT)
302.1   302.2     302.3	Practical tips and tricks in lung ablation A. Gillams (London/UK) Radiofrequency of bone tumours: from palliation to cure T. de Baère (Villejuif/FR) Stereotaxy and robotic for radiofrequency ablation: toys or tools? R. Bale (Innsbruck/AT)
	17:30-18:00
SY 601	Microsulis Medical	Main Auditorium
	2.45GHz microwave ablation: top tips to improve outcomes in the liver and lung
	Moderator: T.K. Helmberger (Munich/DE)
601.1       601.2	Microwave at 2.45GHz in the lung, better than RFA: own experience and current results P.L. Pereira (Heilbronn/DE)  Ten top tips for optimising outcomes in microwave ablation of the liver D.J. Breen (Southampton/UK)

Thursday, April 26

	11:45-12:30
SY 901	Terumo Europe	Main Auditorium
	DC Bead, what's new?
	Moderator: P.L. Pereira (Heilbronn/DE)
901.1     901.2     901.3	SPACE clinical study: what did we learn regarding DEBDOX? R. Lencioni (Pisa/IT) DC BeadM1 loaded with doxorubicin: results on a Vx2 pre-clinical model J.-F.H. Geschwind (Baltimore, MD/US) DEBIRI overview of clinical data and technical recommendations G. Narayanan (Miami, FL/US)
	12:30-13:15
SY 902	AngioDynamics	Main Auditorium
	Clinical experience with irreversible electroporation
	Moderator: R. Lencioni (Pisa/IT)
902.1     902.2     902.3	Irreversible electroporation (IRE) in the treatment of HCC – safety and efficacy R. Lencioni (Pisa/IT) Irreversible electroporation – the University of Miami experience G. Narayanan (Miami, FL/US)  Irreversible electroporation (IRE) in locally advanced pancreatic cancer: multi-institutional evaluation and planned initiation of Phase II clinical trials R.C.G. Martin (Louisville, KY/US)
	17:00-17:30
SY 1201	Bracco	Main Auditorium
	New trends for the use of contrast enhanced ultrasound in the interventional treatment of tumours
	Moderator: L. Bolondi (Bologna/IT)
1201.1     1201.2	Clinical benefits of real time monitoring using CEUS during ablations L. Solbiati (Busto Arsizio/IT) Perisurgical breast tumour diagnosis: current practice and future applications of CEUS A. Sever (Maidstone/UK)

Friday, April 27

	11:45-12:30
SY 1501	Sirtex Medical	Main Auditorium
	Liver-directed radiotherapy in interventional oncology
	Moderator: E. Cortesi (Rome/IT)
1501.1     1501.2   1501.3	SIR-Spheres microspheres – a unique concept for inoperable liver metastases J.I. Bilbao (Pamplona/ES) SIR-Spheres microspheres in HCC R. Golfieri (Bologna/IT) Questions and answers
	12:30-13:15
SY 1502	Siemens AG Healthcare Sector	Main Auditorium
	Shaping the future of image-based diagnosis and therapy in interventional oncology
	Moderator: R. Lencioni (Pisa/IT)
1502.1     1502.2	Transarterial liver therapies: new materials and technical requirements P.L. Pereira (Heilbronn/DE) CT-guidance in 3D for interventional oncology Michael Lell (Erlangen/DE)
	15:30-16:00
SY 1701	Merit Medical	Main Auditorium
	HepaSphere Microspheres for HCC: patient outcomes and considerations in embolic sizing
	Moderator: R. Salem (Chicago, IL/US)
1701.1     1701.2	HepaSphere Microspheres for unresectable HCC: clinical results M. Grosso (Cuneo/IT)  HepaSphere Microspheres: pre-clinical comparative data for smaller size HepaSphere Microspheres V. Verret (Jouy-en-Josas/FR)